From: The development and validation of oral cancer staging using administrative health data
Model 1 | Model 2 | Model 3 | Model 4 | |
---|---|---|---|---|
Treatment | ˇ | ˇ | ˇ | |
Site | ˇ | ˇ | ˇ | |
Treatment*site | ˇ | |||
C-statistic | ||||
Male | ||||
Stage I versus II-IV | ||||
20-44 | 0.76 | 0.60 | 0.78 | 0.83 |
45-64 | 0.78 | 0.62 | 0.80 | 0.82 |
> = 65 | 0.77 | 0.68 | 0.81 | 0.86 |
Stage I-II versus III-IV | ||||
20-44 | 0.75 | 0.63 | 0.78 | 0.83 |
45-64 | 0.77 | 0.58 | 0.78 | 0.79 |
> = 65 | 0.81 | 0.68 | 0.86 | 0.90 |
Stage I-III versus IV | ||||
20-44 | 0.75 | 0.61 | 0.79 | 0.81 |
45-64 | 0.77 | 0.64 | 0.79 | 0.81 |
> = 65 | 0.76 | 0.73 | 0.86 | 0.89 |
Female | ||||
Stage I versus II-IV | ||||
20-44 | 0.93 | 0.70 | 1.00 | 1.00 |
45-64 | 0.87 | 0.82 | 0.89 | 0.92 |
> = 65 | 0.88 | 0.92 | 0.98 | 0.98 |
Stage I-II versus III-IV | ||||
20-44 | 0.93 | 0.70 | 1.00 | 1.00 |
45-64 | 0.90 | 0.85 | 0.93 | 0.95 |
> = 65 | 0.87 | 0.97 | 1.00 | 1.00 |
Stage I-III versus IV | ||||
20-44 | 0.98 | 0.77 | 0.98 | 0.98 |
45-64 | 0.91 | 0.87 | 0.96 | 0.96 |
> = 65 | 0.84 | 0.86 | 0.92 | 0.94 |